Drug · DIN 02395371
CINRYZE
SINGLE-USE VIALS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since February 10, 2026; first marketed March 8, 2016.
- Drug Identification Number (DIN)
- 02395371
- Company (DIN owner)
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Schedule
- Schedule D
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- C1-inhibitor, plasma derived B06AC01
- Class
- Human
- Record last updated
- August 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| C1 ESTERASE INHIBITOR (HUMAN) | 500 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 18, 2020: NOC 24878New Drug Submission (NDS) · Transfer of drug identification number, labelling updates
- March 12, 2020: NOC 23333New Drug Submission (NDS) · Merger/Buyout
- October 19, 2012: NOC 13738New Drug Submission (NDS)